Cart
sales@molnova.com
Lotrifen
CAS No. 66535-86-2
Lotrifen( —— )
Catalog No. M34000 CAS No. 66535-86-2
Lotrifen (Privaprol), an agent of non-hormonal antifertility, causes the arrest and involution of pregnancy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 255 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | 1423 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLotrifen
-
NoteResearch use only, not for human use.
-
Brief DescriptionLotrifen (Privaprol), an agent of non-hormonal antifertility, causes the arrest and involution of pregnancy.
-
DescriptionLotrifen (Privaprol), an agent of non-hormonal antifertility, causes the arrest and involution of pregnancy. It acts, after the implantation of the blastocyst, directly on the product of conception, which undergoes a slow and gradual degenerative process and ends with the reabsorption or expulsion of it.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66535-86-2
-
Formula Weight279.72
-
Molecular FormulaC16H10ClN3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClC1=CC=C(C=2N=C3C=4C(C=CN3N2)=CC=CC4)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Oxyresveratrol-4,3,5...
Oxyresveratrol-4,3',5'-tri-O-β-D-glucopyranoside
-
UM4118
UM4118 (N-quinolin-8-ylpyridine-2-carboxamide) is a copper ion carrier that triggers an atypical form of mitochondria-based cell death (cuproptosis).
-
Eugeniin
Tellimagrandin II (Eugeniin), with oral activity, is the first intermediate of the ellagitannin series derived from 4C1-glucose. It inhibits the resistance of Staphylococcus aureus by disrupting the integrity of the cell wall, leading to the loss of cytoplasmic contents. Additionally, Tellimagrandin II exhibits anti-inflammatory effects and inhibits acetylcholinesterase (AChE) activity, improving memory impairment. Tellimagrandin II holds potential for research in the fields of antibacterial, anti-inflammatory, and neurodegenerative diseases.
